Paper Abstracts of the ISPD 17 th International Conference on Prenatal Diagnosis and Therapy 1-1 Noninvasive prenatal testing in China : Results and learning from a clinical study of more than 50 , 000 pregnancies
Daixing Zhou,Densheng Liang,Weigang Lv,Feng Tian,Zhuo Song,Jianguang Zhang,Yuanyuan Ren,Di Chen,Jingjing Zhao,Ke,Zhou,Ying Hou,Yang Gao,Lingqian Wu,Taylor Jensen,Sung Kim,Zhanyang Zhu,Christine Chin,Tim Lu,Cosmin Deciu,Dirk van,den Boom,Mathias Ehrich
2013-01-01
Abstract:OBJECTIVES: Several well-designed clinical trials, including two trials conducted in China, have demonstrated the feasibility and accuracy of sequencing based noninvasive prenatal test (NIPT). However, the failure rate, sensitivity and specificity of NIPT for a large population in the real life clinical setting have not been reported. METHOD: Within a period of 15 months, under a provincially approved program, we applied NIPT to more than 50,000 pregnant women of various demographic and maternal background, using the published methodology developed for the clinical trials that we had conducted (Prenatal Diagnosis, 2013, Vol. 32: 1-7). RESULTS: We found that the detection sensitivity and specificity for trisomy 21, trisomy 18, and trisomy 13 were almost the same as we had observed in the clinical trials, each at >99%. The failure rate was at ~0.6%, better than the rate that we had encountered during the clinical trials. We also observed that NIPT could accurately detect aneuploidies of other chromosomes, with slightly higher “false positive” rates mainly caused by confined placenta mosaicism (CPM) and maternal mosaicism (MM). CONCLUSIONS: Our results indicate that NIPT can be applied to real life clinical setting, with low failure rate and high accuracy. The results suggested that CPM and MM should be factored into the interpretation of the data, particularly for aneuploidies other than trisomy 21. 1-2